Bristol Myers Squibb reported $2.47B in Cost of Sales for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Cost Of Sales Change
Abbott ABT:US $ 4987M 267M
Abbvie ABBV:US $ 4021M 259M
ALKERMES ALKS:US 55.16M 1.48M
Amgen AMGN:US $ 1561M 157M
Astrazeneca AZN:US 2.28B 790M
AstraZeneca AZN:LN 2279M 790M
Biogen BIIB:US $ 753.9M 93.8M
Bristol Myers Squibb BMY:US $ 2471M 115M
Catalent CTLT:US $ 850M 38M
Coherus Biosciences CHRS:US $ 9.37M 2.73M
Eli Lilly And LLY:US $ 2072.1M 21.9M
Endo International Ordinary Shares ENDP:US $ 179.76M 42.71M
Gilead Sciences GILD:US $ 1424M 1203M
GlaxoSmithKline GSK:LN 3645M 30M
Horizon Pharma HZNP:US $ 215.06M 26.45M
Intercept Pharmaceuticals ICPT:US $ 0.76M 0.26M
JAZZ PHA JAZZ:US $ 115.28M 20.87M
Johnson & Johnson JNJ:US $ 7598M 357M
Lannett LCI:US $ 75.28M 5.52M
Medtronic MDT:US $ 2543M 110M
Merk MRK:US $ 5334M 1507M
Novartis NOVN:VX SF 3755M 245M
Perrigo Ordinary Shares PRGO:US $ 736.7M 5.8M
Phibro Animal Health PAHC:US $ 167.99M 5.95M
Prestige Brands PBH:US $ 118.07M 1.34M
Regeneron Pharmaceuticals REGN:US $ 404.9M 577.7M
Revance Therapeutics RVNC:US $ 7.89M 12K
Teva Pharmaceutical Industries TEVA:US $ 1859M 116M
United Therapeutics UTHR:US $ 25.9M 8.7M
Zoetis ZTS:US $ 565M 31M